(19)
(11) EP 4 045 054 A1

(12)

(43) Date of publication:
24.08.2022 Bulletin 2022/34

(21) Application number: 20876826.7

(22) Date of filing: 14.10.2020
(51) International Patent Classification (IPC): 
A61K 31/56(2006.01)
A61K 47/55(2017.01)
C07H 9/00(2006.01)
A61K 47/54(2017.01)
C07H 1/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 47/554; A61K 47/6911; A61K 47/6923; A61K 47/6929; A61K 47/542; A61K 45/06; A61K 31/136; A61K 31/555; A61K 31/282; A61K 31/704; A61K 31/405; A61K 31/58; C07J 43/003
 
C-Sets:
  1. A61K 31/405, A61K 2300/00;
  2. A61K 31/58, A61K 2300/00;
  3. A61K 31/136, A61K 2300/00;
  4. A61K 31/555, A61K 2300/00;
  5. A61K 31/282, A61K 2300/00;
  6. A61K 31/704, A61K 2300/00;

(86) International application number:
PCT/US2020/055585
(87) International publication number:
WO 2021/076630 (22.04.2021 Gazette 2021/16)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 14.10.2019 US 201962914950 P
18.11.2019 US 201916687368

(71) Applicant: The Regents of the University of California
Oakland, CA 94607-5200 (US)

(72) Inventors:
  • MEI, Kuo-Ching
    Oakland, CA 94607-5200 (US)
  • MENG, Huan
    Oaklanc, CA 94607- 5200 (US)
  • NEL, Andre E.
    Oakland, CA 94607-5200 (US)

(74) Representative: Mewburn Ellis LLP 
Aurora Building Counterslip
Bristol BS1 6BX
Bristol BS1 6BX (GB)

   


(54) NANO-ENABLED IMMUNOTHERAPY IN CANCER